Ten63 Therapeutics Launches BEYOND-Alpha, with Chugai Pharmaceutical as First Participant
<p>Early adopter program aims to scale Ten63's BEYOND platform across challenging pharmaceutical targets DURHAM, N.C., Nov. 18, 2026 /PRNewswire/ -- Ten63 Therapeutics, Inc. ("Ten63") today announced the launch of BEYOND-Alpha, an early adopter program through which select pharmaceutical...</p>
Read original article ↗